CareFusion Corp. Insider Thomas Leonard Sells 1,250 Shares (CFN)
CareFusion Corp. (NYSE:CFN) Insider Thomas Leonard unloaded 1,250 shares of CareFusion Corp. stock on the open market in a transaction dated Monday, January 6th. The shares were sold at an average price of $39.48, for a total value of $49,350.00. Following the completion of the sale, the insider now directly owns 59,799 shares in the company, valued at approximately $2,360,865. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
Shares of CareFusion Corp. (NYSE:CFN) traded up 1.29% during mid-day trading on Tuesday, hitting $40.03. The stock had a trading volume of 1,771,283 shares. CareFusion Corp. has a 52-week low of $29.10 and a 52-week high of $40.29. The stock has a 50-day moving average of $39.39 and a 200-day moving average of $38.07. The company has a market cap of $8.460 billion and a price-to-earnings ratio of 23.14.
CareFusion Corp. (NYSE:CFN) last released its earnings data on Thursday, November 7th. The company reported $0.44 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.39 by $0.05. The company had revenue of $830.00 million for the quarter, compared to the consensus estimate of $818.34 million. During the same quarter in the previous year, the company posted $0.44 earnings per share. The company’s revenue for the quarter was down .8% on a year-over-year basis. On average, analysts predict that CareFusion Corp. will post $2.35 earnings per share for the current fiscal year.
CFN has been the subject of a number of recent research reports. Analysts at Zacks reiterated a “neutral” rating on shares of CareFusion Corp. in a research note to investors on Tuesday, December 24th. They now have a $42.00 price target on the stock. Separately, analysts at Bank of America Corp. reiterated a “buy” rating on shares of CareFusion Corp. in a research note to investors on Wednesday, December 18th. They now have a $45.00 price target on the stock, up previously from $43.00. Finally, analysts at Goldman Sachs Group Inc. downgraded shares of CareFusion Corp. from a “neutral” rating to a “sell” rating in a research note to investors on Tuesday, December 17th. They now have a $36.00 price target on the stock, up previously from $35.00. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $40.82.
CareFusion Corporation (NYSE:CFN) is a global medical technology company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.